The complement inhibitors in COVID-19: Future expectations

[No abstract available]

Authors
Korotchaeva Y.1 , Kozlovskaya N. 2 , Bobrova L.1 , Kamyshova E.1 , Demyanova K. 2 , Moiseev S.1
Journal
European Review for Medical and Pharmacological Sciences
Publisher
Verduci Editore
Number of issue
12
Language
English
Pages
6480-6481
Status
Published
Link
External link
DOI
10.26355/eurrev_202006_21628
Volume
24
Year
2020
Organizations
  • 1 Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • 2 Peoples' Friendship University of Russia, Moscow, Russian Federation
Keywords
complement component C5a; complement inhibitor; eculizumab; complement inhibitor; eculizumab; monoclonal antibody; adult respiratory distress syndrome; coronavirus disease 2019; cytokine storm; disease predisposition; disease severity; drug efficacy; drug inhibition; heredity; human; infection risk; Letter; lung biopsy; lung injury; multiple organ failure; mutation; nonhuman; prediction; protein blood level; Severe acute respiratory syndrome coronavirus 2; thrombotic thrombocytopenic purpura; treatment duration; Betacoronavirus; Coronavirus infection; motivation; pandemic; virus pneumonia; Antibodies, Monoclonal, Humanized; Betacoronavirus; Complement Inactivating Agents; Coronavirus Infections; Humans; Motivation; Pandemics; Pneumonia, Viral
Date of creation
02.11.2020
Date of change
02.11.2020
Short link
https://repository.rudn.ru/en/records/article/record/65222/
Share

Other records

SPECIFIC INFLUENZA THERAPY: CURRENT STATE AND PROSPECTS (REVIEW)

Article
Odnovorov A.I., Grebennikova T.V., Pleteneva T.V.
Разработка и регистрация лекарственных средств. Общество с ограниченной ответственностью "Фармконтракт". Vol. 9. 2020. P. 83-91

THE INFLUENCE OF DEUTERIUM ON THE PROPERTIES OF PHARMACEUTICAL SUBSTANCES (REVIEW)

Article
Syroeshkin A.V., Elizarova T.E., Pleteneva T.V., Uspenskaya E.V., Levitskaya O.V., Zlatskiy I.A., Maksimova T.V.
Разработка и регистрация лекарственных средств. Общество с ограниченной ответственностью "Фармконтракт". Vol. 9. 2020. P. 24-32